QualityStocksNewsBreaks – Endonovo Therapeutics, Inc. (ENDVD) Announces Issuance of U.S. Patent, Expansion of its SofPulse(R) Intellectual Property Portfolio

Endonovo Therapeutics (OTCQB: ENDVD) today announced that the United States Patent and Trademark Office (“USPTO”) has issued U.S. Patent No. 15217855, which is directed to the usage of an Apparatus and Method for Electromagnetic Treatment of Neurological Injury or Condition Caused by a Stroke. “We are extremely pleased with the continued development and expansion of our patent portfolio,” Endonovo Therapeutics CEO Alan Collier said in the news release. “This new issuance continues to expand the breadth and depth of our SofPulse(R) unit intellectual property portfolio and the issuance of this patent is another step in the development of a robust patent portfolio relating to SofPulse(R).”

To view the full press release, visit http://ibn.fm/xdBfC

About Endonovo Therapeutics

Endonovo Therapeutics, Inc. is a commercial-stage developer of non-invasive wearable Electroceuticals(R) therapeutic devices. The Company’s current portfolio of commercial and clinical-stage wearable Electroceuticals(R) therapeutic devices addresses wound healing, pain, post-surgical pain and edema, cardiovascular disease, chronic kidney disease, and Central Nervous System (“CNS”) Disorders, including traumatic brain injury (“TBI”), acute concussions, post- concussion syndrome and multiple sclerosis. The Company’s non-invasive Electroceutical(R) therapeutic device, SofPulse(R), using pulsed short-wave radiofrequency at 27.12 MHz has been FDA-Cleared and CE Marked for the palliative treatment of soft tissue injuries and post-operative pain and edema, and has CMS National Coverage for the treatment of chronic wounds. The Company’s current portfolio of pre-clinical stage Electroceuticals(R) therapeutic devices address chronic kidney disease, liver disease non-alcoholic steatohepatitis (“NASH”), cardiovascular and peripheral artery disease (“PAD”), and ischemic stroke. The Company’s non-invasive, wearable Electroceuticals(R) therapeutic devices work by restoring key electrochemical processes that initiate anti-inflammatory and growth factor cascades necessary for healing to occur. For more information, visit www.Endonovo.com.

NOTE TO INVESTORS: The latest news and updates relating to ENDVD are available in the company’s newsroom at http://ibn.fm/ENDV

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php